China SXT Pharmaceuticals (SXTC) Enterprise Value (2018 - 2025)
Historic Enterprise Value for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to -$21.2 million.
- China SXT Pharmaceuticals' Enterprise Value fell 1450.21% to -$21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.2 million, marking a year-over-year decrease of 1450.21%. This contributed to the annual value of -$18.1 million for FY2025, which is 5011.3% down from last year.
- Per China SXT Pharmaceuticals' latest filing, its Enterprise Value stood at -$21.2 million for Q3 2025, which was down 1450.21% from -$18.1 million recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Enterprise Value ranged from a high of -$3.0 million in Q3 2022 and a low of -$31.3 billion during Q3 2021
- In the last 5 years, China SXT Pharmaceuticals' Enterprise Value had a median value of -$16.5 million in 2022 and averaged -$3.1 billion.
- Per our database at Business Quant, China SXT Pharmaceuticals' Enterprise Value crashed by 30241681.71% in 2021 and then skyrocketed by 9999.05% in 2022.
- Over the past 5 years, China SXT Pharmaceuticals' Enterprise Value (Quarter) stood at -$31.3 billion in 2021, then soared by 99.99% to -$3.0 million in 2022, then tumbled by 284.6% to -$11.5 million in 2023, then crashed by 61.47% to -$18.5 million in 2024, then dropped by 14.5% to -$21.2 million in 2025.
- Its last three reported values are -$21.2 million in Q3 2025, -$18.1 million for Q1 2025, and -$18.5 million during Q3 2024.